N-propionyl-4-S-cysteaminylphenol exerts selective melanocytotoxicity through apoptotic process

Sapporo Medical Journal

Volumn 67, Issue 1-2, 1998, Pages 23-37

  Minamitsuji, Yasushi ^a   Sugiyama, Sadao ^a   Singh, Shradha ^b   Jimbow, Kowichi ^a,c  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF ALBERTA   (Canada)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Oxidative stress; Phenolic thioether amine

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 S CYSTEAMINYLPHENOL; ANTINEOPLASTIC AGENT; DEPIGMENTING AGENT; DNA; DNA NUCLEOTIDYLEXOTRANSFERASE; FLUORESCEIN ISOTHIOCYANATE; MONOPHENOL MONOOXYGENASE; N ACETYL 4 S CYSTEAMINYLPHENOL; N PROPIONYL 4 S CYSTEAMINYLPHENOL; PHENOL DERIVATIVE; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DEPIGMENTATION; DOSE RESPONSE; DRUG STRUCTURE; FEMALE; FIBROBLAST; GROWTH INHIBITION; HAIR FOLLICLE; INTRAPERITONEAL DRUG ADMINISTRATION; KERATINOCYTE; MELANOCYTE; MOUSE; NONHUMAN;

EID: 0031692129     PISSN: 0036472X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. thed. New York, McGraw Hill, 1993. 261-289.
2. Jimbow K, Iwashina T, Alena F, et al. Exploitation of pigment biosynthesis pathway as a selective chemotherapeutic approach for malignant melanoma. J Invest Dermatol 1993, 100 : 231S-238S.
3. Padgette SR, Herman HH, Han JH, et al. Anti-hypertensive activities of phenyl aminoethyl sulfides, a class of synthetic substrates for dopamine beta-hydroxylase J Med Chem 1984, 27 : 1354-1357.
4. Pankovich JM, Jimbow K, Ito S. 4-S-cysteaminylphenol and its analogues as substrates for tyrosinase and monoamine oxidase. Pigment Cell Res 1990, 3 : 146-149.
5. Inoue S, Ito S, Wakamatsu K, et al. Mechanism of growth inhibition of melanoma cells by 4-S-cysteamlnylphenol and its analogues Biochem Pharmacol 1990, 39 : 1077-1083.
6. Miura T, Jimbow K, Ito S. The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its N-acetyl derivative. Int J Cancer 1990. 46 : 931-934.
7. Alena F, Jimbow K, Ito S. Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo. Cancer Res 1990, 30 : 3743-3747.
8. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980, 284: 555-556.
9. Kerr JFR,- Wyllie AH. Currie AR. Apoptosis : a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26 : 239-257.
10. Wyllie AH, Kerr JFR, Currie AR. Cell death : the significance of apoptosis. Inv Rev Cytol 1980, 68 : 251-306.
11. Peitsch MC, Polzar B, Stephan H, et al. Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO 1993, 12 : 371-377.
12. Kaufmann SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs : a cautionary note. Cancer Res 1989, 49 : 5870-5878.
13. Borner MM, Myers CE, Sartor O, et al. Druginduced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res 1995, 55 : 2122-2128.
14. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993, 75 : 229-240.
15. Hockenbery DM, Oltvai ZN, Yin X-M, et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993, 75: 241-251.
16. Tandon M, Jimbow K. Synthesis of mono- and di-propionyl derivatives of cysteaminylphenol [Abstract]. J Invest Dermatol 1995, 104 : 692.
17. Bennett DC, Cooper PJ, Dexter TJ, et al. Cloned mouse melanocyte lines carring the germline mutations albino and brown : complementation in culture. Development 1989, 105 : 379-385.
18. Sviderskaya EV, Wakeling WF, Bennett DC. A cloned, immortal line of murine melanoblasts inducible to differentiate to melanocytes. Development 1995, 121 : 1547-1557.
19. Ito Y, Jimbow K. Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse : rational basis for its application to melanoma chemotherapy. Cancer Res 1987, 47 : 3278-3284.
20. Miura S, Ueda T, Jimbow K, et al. Synthesis of cysteinylphenol, cysteaminylphenol and related compounds and in vivo evaluation of antimelanoma effect. Arch Dermatol Res 1987, 279 : 219-225.
21. Jimbow M, Marusyk H, Jimbow K. The in vivo melanocytotoxicity and depigmenting potency of N-2, 4-actoxyphenyl thioethyl acetamide in the skin and hair. Br J Dermatol 1995, 133 : 526-536.
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival : Application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65 : 55-63.
23. Wong M, Jimbow K. Selective cytotoxicity of N-acetyl-4-S-cysteaminylphenol on follicular melanocytes of black mice. Br J Dermatol 1991, 124 : 56-61.
24. Ito S, Kato T, Ishikawa K, et al Mechanism of selective toxicity of 4-s-cysteinylphenol and 4-s-cysteaminylphenol to melanocytes. Biochem Pharmacol 1987, 36 : 2007-2011.
25. Yamada K, Jimbow K, Engelhardt R, Ito S. Selective cytotoxicity of a phenolic melanin precursor, 4-S-cysteaminylphenol, on in vitro melanoma cells. Biochem Pharmacol 1989, 38 : 2217-2221.
26. Hockenbery DM, Zutter M, Hickey W, et al. BCL-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991, 88 : 6961-6965.
27. Kane DJ, Sarafian TA, Anton R, et al. Bcl-2 inhibition of neural death : decreased generation of reactive oxygen species. Science 1993, 262 : 1274-1277.
28. Hedley DW, McCulloch EA. Generation of reactive oxygen intermediates after treatment of blasts of acute myeloblastic leukemia with cytosine arabinoside : role of bcl-2. Leukemia 1996, 10 : 1143-1149.
29. Alena F, Iwashina T, Gili A, Jimbow K. Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine. Cancer Res 1994, 54 : 2661-2666.
30. Alena F, Dixon W, Thomas P, Jimbow K. Glutathione plays a key role in the depigmenting and melanocytotoxic action of N-acetyl-4-S-cysteaminylphenol in black and yellow hair follicles. J Invest Dermatol 1995, 104 : 792-797.
31. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine : its reaction with hydrogen peroxide, hydroxyl radical, Superoxide, and hypochlorous acid. Free Rad Biol Med 1989, 6 : 593-597.
32. Yohn JJ, Norris DA, Yrastorza DG, et al. Disparate antioxidant enzyme activities in cultured human cutaneous fibroblasts, keratinocytes, and melanocytes. J Invest Dermatol 1991, 97 : 405-409.
33. Silver AF, Chase HB, Potten CS. Melanocyte precursor cells in the hair follicle germ during the dormant stage (telgen). Experientia 1969, 25 : 299-301.
34. Sugiyama S, Kukita A. Melanocyte reservoir in the hair follicles during the hair growth cycle : an electron microscope study. In : Toda K, et al. editors. Biology and disease of the hair. Baltimore, University Park Press, 1976, 181-200.
35. Grichnik JM, Ali WN, Burch JA, et al. KIT Expression Reveals a Population of Precursor Melanocytes in Human Skin. J Invest Dermatol 1996, 106 : 967-971.
36. Okura M, Maeda H, Nishikawa S, Mizoguchi M. Effects of monoclonal anti-c-Kit antibody (ACK2) on melanocytes in new born mice. J Invest Dermatol 1995, 105 : 322-328.
37. Slominski A, Paus R, Plonka P, et al. Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ. J Invest Dermatol 1996, 106 : 1203-1211.
38. Jimbow K. N-Acetyl-4-S-Cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma. Arch Dermatol 1991, 127 : 1528-1534.